Integra Lifesciences Holdings Corp (NASDAQ: IART) is -51.71% lower on its value in year-to-date trading and has touched a low of $20.76 and a high of $45.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IART stock was last observed hovering at around $20.85 in the last trading session, with the day’s gains setting it 0.18%.
Currently trading at $21.03, the stock is -12.15% and -23.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.36 million and changing 0.86% at the moment leaves the stock -38.94% off its SMA200. IART registered -50.05% loss for a year compared to 6-month loss of -53.01%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -32.96% gain in the last 1 month and extending the period to 3 months gives it a -23.19%, and is -1.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.37% over the week and 4.43% over the month.
Integra Lifesciences Holdings Corp (IART) has around 5329 employees, a market worth around $1.63B and $1.57B in sales. Current P/E ratio is 71.26 and Fwd P/E is 8.39. Profit margin for the company is 1.51%. Distance from 52-week low is 1.30% and -53.70% from its 52-week high. The company has generated returns on investments over the last 12 months (0.67%).
with sales reaching $375.78M over the same period.The EPS is expected to shrink by -20.97% this year, but quarterly earnings will post 4.60% year-over-year. Quarterly sales are estimated to shrink -2.20% in year-over-year returns.
348.0 institutions hold shares in Integra Lifesciences Holdings Corp (IART), with institutional investors hold 110.79% of the company’s shares. The shares outstanding are 78.17M, and float is at 64.98M with Short Float at 6.77%. Institutions hold 95.09% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.98 million shares valued at $247.47 million. The investor’s holdings represent 8.9802 of the IART Shares outstanding. As of 2024-03-31, the second largest holder is BLACKROCK INC. with 6.65 million shares valued at $235.66 million to account for 8.5518 of the shares outstanding. The other top investors are CAPITAL RESEARCH GLOBAL INVESTORS which holds 5.92 million shares representing 7.6143 and valued at over $209.83 million, while MORGAN STANLEY holds 6.3222 of the shares totaling 4.91 million with a market value of $174.22 million.
Integra Lifesciences Holdings Corp (IART) Insider Activity
The most recent transaction is an insider sale by Mosebrook Jeffrey, the company’s SVP, Fin & Princ Acct Officer. SEC filings show that Mosebrook Jeffrey sold 1,191 shares of the company’s common stock on Aug 19 ’24 at a price of $21.58 per share for a total of $25701.0. Following the sale, the insider now owns 36088.0 shares.
Integra Lifesciences Holdings Corp disclosed in a document filed with the SEC on May 23 ’24 that ESSIG STUART (Exec. Chairman of the Board) bought a total of 52,641 shares of the company’s common stock. The trade occurred on May 23 ’24 and was made at $28.49 per share for $1.5 million. Following the transaction, the insider now directly holds 0.49 million shares of the IART stock.
Still, SEC filings show that on May 21 ’24, HILL BARBARA B (Director) acquired 36,350 shares at an average price of $27.40 for $1.0 million. The insider now directly holds 36,350 shares of Integra Lifesciences Holdings Corp (IART).
